PMID: 2493376Feb 1, 1989Paper

Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia

European Journal of Pediatrics
T SumerM al-Fadil

Abstract

Thirty-three children with leukemia who had neutropenia and fever were randomized to receive cefataxim and amikacin, versus the same antibiotics plus intravenous gammaglobulin (i.v. IgG). Duration of neutropenia, hospitalization and the interruption of chemotherapy were not different in the two groups; however, duration of fever was significantly shorter in the i.v. IgG group.

References

Oct 1, 1984·Annals of Internal Medicine·C Cunningham-RundlesR A Good
Mar 30, 1984·The American Journal of Medicine·B Pirofsky
Mar 30, 1984·The American Journal of Medicine·A Montanaro, B Pirofsky
Mar 30, 1984·The American Journal of Medicine·R U Sorensen, S H Polmar
Jan 1, 1984·The American Journal of Medicine·R M Ratzan

❮ Previous
Next ❯

Citations

Jul 11, 2009·Clinical Reviews in Allergy & Immunology·Shaye KivityYehuda Shoenfeld
Apr 3, 2007·Transfusion Medicine Reviews·David AndersonGail Rock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.